Gapping down
In reaction to earnings/guidance:
- WEAV -26.4%, SNOW -19.9% (also to acquire Streamlit), RSI -18.3%, BJ -14.9%, BURL -11.6%, VEEV -10.8%, ASND -7.1% (also provides business update), OKTA -7%, BIG -6.6%, AEO -4.7%, KREF -4.3% (also announces stock offering) HEAR -3.1%, AI -1%
Other news:
- NCNA -54.4% (announces discontinuation of NuTide:121 study)
- RXRX -4.7% (provided updated guidance on clinical trial starts)
- SAFE -3.8% (commences public offering of 1.75 mln shares; announces concurrent private placement)
- VBTX -2.9% (stock offering)
- AZN -2.2% (Nirsevimab significantly protected infants against RSV disease in Phase III MELODY trial)
- PD -1.3% (to acquire Catalytic)
- LITE -1.3% ( announces $750 million convertible notes offering due in 2028; increases share repurchase authorization to $1 billion)
- SNY -1.1% (Nirsevimab significantly protected infants against RSV disease in Phase 3 trial )
Analyst comments:
- INTC -2% (downgraded to Underweight from Equal-Weight at Morgan Stanley)
- QRVO -1.9% (downgraded to Equal-Weight from Overweight at Morgan Stanley)
- NBIX -1.6% (downgraded to Neutral from Overweight at Piper Sandler)
- TER -1.5% (downgraded to Equal-Weight from Overweight at Morgan Stanley)